| 摘要 |
The present invention relates to a method of treating dementia or cognitive deficits associated with Alzheimer's disease or Parkinson's disease in a mammal, including a human, by administering to the mammal a D4 dopamine receptor in combination with an acetylcholine esterase inhibitor. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a D4 dopamine receptor and an acetylcholine esterase inhibitor.
|
